We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
TIDMGSK
RNS Number : 5668O
GSK PLC
01 February 2023
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Dr H Barron ==== ======================================== ==================================================== b) Position/status Non-Executive Director ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W2044 instrument ==== ======================================== ==================================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 12 January 2023 ==== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $35.5198 1,421.208 ====================== ========================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ======================================================== e) Date of the transaction 2023-01-30 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr J Ford ==== ======================================== ==================================================== b) Position/status SVP and Group General Counsel, Legal and Compliance ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W2044 instrument ==== ======================================== ==================================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 12 January 2023 ==== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $35.5198 276.356 ====================== ========================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ======================================================== e) Date of the transaction 2023-01-30 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Shobie Ramakrishnan ==== ======================================== ==================================================== b) Position/status Chief Digital and Technology Officer ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W2044 instrument ==== ======================================== ==================================================== b) Nature of the Acquisition of ADSs following the re-investment transaction of dividends paid to shareholders on 12 January 2023 ==== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $35.5198 49.400 ====================== ========================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ======================================================== e) Date of the transaction 2023-01-30 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ====================================================, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSSMSAFEDSELE
(END) Dow Jones Newswires
February 01, 2023 10:30 ET (15:30 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions